Dr. Adrian Carlo Dews Sr., DO

Dr. Dews practices at Bon Secours Harbour View Medical Center in Suffolk, Virginia, part of Bon Secours Mercy Health.

Dr. Dews' NPI, 1003045790, was assigned on July 2, 2009. Dr. Dews holds Virginia license 0102203022.

Dr. Dews' primary practice is Bon Secours Harbour View Medical Center, at 1020 Bon Secours Drive, Suffolk, VA 23435 in Suffolk City. The practice phone is (757) 673-5917.

Dr. Dews' primary practice is Bon Secours Harbour View Medical Center in Suffolk, Virginia, part of Bon Secours Mercy Health. The medical group on file is Emergency Medicine Physicians (EMP). Dmand AI also links Dr. Dews to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dews practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Dews' primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Dews is licensed in Virginia.

CMS data shows 107 Medicare services from Dr. Dews across 3 procedure codes in 2024, for 113 Medicare patients. Medicare paid $12,588 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Dr. Dews in 2024. The largest group is 75 to 84, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dews' median patient age at 47, with 66% women.

In 2024, Dr. Dews wrote 106 Medicare Part D claims for 69 patients. 95% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $44 in total drug cost. In 2020, CMS named 104 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Dews for performance year 2024, reported as part of a group. Dr. Dews accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Dews to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 2 general payments to Dr. Dews from 2 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. CSL Behring paid the most, $39.